SCHEMBL41070

SCHEMBL41070

CC(O)Cc1ccc(C(C)(C)c2ccc(CC(C)O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.44
ESR2 Q92731 5/20 0.44
TSHR P16473 2/20 0.44
CYP3A4 P08684 2/20 0.44
SLC6A2 P23975 2/20 0.44
AR P10275 2/20 0.44
HPGD P15428 1/20 0.44
SLC6A4 P31645 1/20 0.44
HTR6 P50406 1/20 0.44
ESRRG P62508 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TP53 P04637 1/20 0.44
RORC P51449 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TAAR1 Q96RJ0 3/20 0.38
HTT P42858 1/20 0.38
HIF1A Q16665 1/20 0.38
ACACB O00763 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8679307 0.87 TSHR (0.58) TSHRTP53ACACB
SCHEMBL18253225 0.87 TSHR (0.58) TSHRTP53ACACB
SCHEMBL8007519 0.84 ESR1 (0.46) ESR1ESR2TSHRCYP3A4SLC6A2
SCHEMBL196800 0.83 TAAR1 (0.48) ESR1ESR2TSHRSLC6A2SLC6A3
SCHEMBL3200869 0.82 ESR1 (0.41) ESR1ESR2TSHRSLC6A2TP53
SCHEMBL19646258 0.82 ADORA3 (0.48) ESR1ESR2TSHRTP53TAAR1
SCHEMBL2423098 0.81 ALDH1A1 (0.47) ALDH1A1TAAR1
SCHEMBL16868329 0.81 ALDH1A1 (0.47) ALDH1A1TAAR1
SCHEMBL4410153 0.79 AR (0.49) ESR1ESR2TSHRCYP3A4SLC6A2
SCHEMBL8985983 0.77 TAAR1 (0.43) ESR1ESR2CYP3A4SLC6A2AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046059-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-02-24 US claimed
WO-2011011675-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-01-27 WO claimed
JP-60163913-A None JP disclosed
US-12528888-B2 Process for producing an aqueous polymer dispersion BASF SE (DE) 2026-01-20 US disclosed
WO-2025103901-A1 POLYMER DISPERSIONS FOR COATINGS BASF SE (DE) 2025-05-22 WO disclosed
EP-4389778-A1 AQUEOUS POLYMER DISPERSION FOR COATING COMPOSITIONS BASF SE (DE) 2024-06-26 EP disclosed
CN-114127135-B Process for preparing aqueous polymer dispersions 巴斯夫欧洲公司 2024-05-31 CN disclosed
US-20230348633-A1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2023-11-02 US disclosed
EP-4004058-B1 PROCESS FOR PRODUCING AN AQUEOUS POLYMER DISPERSION BASF SE (DE) 2023-09-06 EP disclosed
US-20230265229-A1 AQUEOUS POLYMER DISPERSION FOR ADHESIVE FORMULATIONS BASF SE (DE) 2023-08-24 US disclosed
EP-4178997-A1 AQUEOUS POLYMER DISPERSION FOR ADHESIVE FORMULATIONS BASF SE (DE) 2023-05-17 EP disclosed
EP-0783004-A1 Process for the production of insoluble-in-water polymers BASF AKTIENGESELLSCHAFT (DE) 1997-07-09 EP disclosed
EP-0504433-B1 LAMINATED FILM AND PRODUCTION THEREOF DAICEL CHEM (JP) 1997-06-18 EP disclosed
WO-1997009359-A1 POWDERY POROUS POLYMERS CONTAINING N-VINYLIMIDAZOL UNITS, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1997-03-13 WO disclosed
WO-1996037525-A1 WATER-SOLUBLE COPOLYMERS CONTAINING POLYMERIZED-IN CROSS-LINKING AGENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1996-11-28 WO disclosed
WO-1996037524-A1 POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1996-11-28 WO disclosed
US-5578372-A Heat-weldable composite films and method of production thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1996-11-26 US disclosed
EP-0504433-A1 LAMINATED FILM AND PRODUCTION THEREOF DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1992-09-23 EP disclosed
JP-S60163913-A HEAT-, FRICTION- AND ABRASION-RESISTANT POLYURETHANE TOYO TIRE & RUBBER CO LTD 1985-08-26 JP disclosed
US-4371644-A Piperidine derivatives and their use as polymer stabilizers SANKYO COMPANY LTD. (JP) 1983-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528888-B2 Process for producing an aqueous polymer dispersion CHRM1, CD14, CHRM2 ESR1 754/4885ESR2 1096/4885TSHR 3841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.